≡ Risteys
R10

Documentation Changelog GitHub Contact & Feedback

Adenocarcinoma and papillary adenocarcinoma of stomach (controls excluding all cancers)

Endpoint Browser PheWeb

C3_STOMACH_ADENO_EXALLC

No definition available.

Endpoint definition

↥
FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Cancer registry: Topography ICD-O-3 C16
Cancer registry: Morphology ICD-O-3 8140|8145
Cancer registry: Behaviour codes 3

1 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

792

diagram downward connector
C3_STOMACH_ADENO_EXALLC

Control definitions

Control exclude C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze DF8

No upset plot: script not run.

No upset table: script not run.

Similar endpoints

↥

List of similar endpoints to Adenocarcinoma and papillary adenocarcinoma of stomach (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 792 204 588
Unadjusted prevalence (%) 0.19 0.09 0.32
Mean age at first event (years) 66.86 63.19 68.13

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: C3_STOMACH_ADENO_EXALLC – Adenocarcinoma and papillary adenocarcinoma of stomach (controls excluding all cancers)
GWS hits: 2

Survival analyses between endpoints

↥

Plot

before Adenocarcinoma and papillary adenocarcinoma of stomach (controls excluding all cancers)
after Adenocarcinoma and papillary adenocarcinoma of stomach (controls excluding all cancers)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Adenocarcinoma and papillary adenocarcinoma of stomach (controls excluding all cancers)

↥

Endpoint not on priority list, no data to show.